Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2426
Saic
SAIC
$5.64B
| $1.32M | ﹤0.01% |
19,000
-35,500
| -65% | -$2.24M |
2016 Q1
2 quarters
|
|
2427
Choice Hotels
CHH
$4.75B
| $1.32M | ﹤0.01% |
29,200
-84,000
| -74% | -$4.03M |
2013 Q2
13 quarters
|
|
2428
Century Communities
CCS
$1.58B
| $1.31M | ﹤0.01% |
61,100
-5,200
| -8% | -$101K |
2015 Q3
4 quarters
|
|
|
JNP
2429
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $1.31M | ﹤0.01% |
236,400
+16,500
| +8% | +$109K |
2013 Q3
12 quarters
|
|
2430
Addus HomeCare
ADUS
$2.14B
| $1.31M | ﹤0.01% |
50,100
-34,100
| -40% | -$750K |
2013 Q2
13 quarters
|
|
|
BWP
2431
DELISTED
Boardwalk Pipeline Partners
BWP
| $1.31M | ﹤0.01% |
+76,400
| New | +$1.29M |
2016 Q3
0 quarters
|
|
2432
Veracyte
VCYT
$3.64B
| $1.31M | ﹤0.01% |
171,774
+104,974
| +157% | +$594K |
2015 Q4
3 quarters
|
|
2433
Apyx Medical
APYX
$109M
| $1.29M | ﹤0.01% |
248,400
+98,800
| +66% | +$320K |
2015 Q1
6 quarters
|
|
2434
Great Elm Group
GEG
$64.2M
| $1.29M | ﹤0.01% |
275,675
+10,202
| +4% | +$55.3K |
2013 Q2
13 quarters
|
|
2435
Sanmina
SANM
$11.7B
| $1.29M | ﹤0.01% |
45,233
-76,424
| -63% | -$2.07M |
2015 Q4
3 quarters
|
|
|
GNMK
2436
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.29M | ﹤0.01% |
+109,000
| New | +$1.05M |
2016 Q3
0 quarters
|
|
2437
Corbus Pharmaceuticals
CRBP
$104M
| $1.28M | ﹤0.01% |
6,307
+1,410
| +29% | +$175K |
2015 Q4
3 quarters
|
|
2438
Deluxe
DLX
$1.06B
| $1.28M | ﹤0.01% |
19,200
-15,600
| -45% | -$1.06M |
2013 Q2
13 quarters
|
|
2439
MDU Resources
MDU
$3.94B
| $1.28M | ﹤0.01% |
132,546
-280,740
| -68% | -$2.56M |
2015 Q4
3 quarters
|
|
|
PGLC
2440
DELISTED
Pershing Gold Corporation. Common Stock
PGLC
| $1.28M | ﹤0.01% |
282,800
+13,390
| +5% | +$59.8K |
2016 Q1
2 quarters
|
|
2441
Lantheus
LNTH
$6.54B
| $1.28M | ﹤0.01% |
154,500
+55,200
| +56% | +$366K |
2016 Q2
1 quarter
|
|
|
VXRT
2442
DELISTED
Vaxart
VXRT
| $1.28M | ﹤0.01% |
60,469
+8,487
| +16% | +$134K |
2013 Q2
13 quarters
|
|
2443
Iridium Communications
IRDM
$5.03B
| $1.27M | ﹤0.01% |
156,600
+93,900
| +150% | +$788K |
2016 Q2
1 quarter
|
|
|
TGB
2444
Trekor Metals
TGB
$3.24B
| $1.27M | ﹤0.01% |
2,647,200
+300,500
| +13% | +$156K |
2013 Q2
13 quarters
|
|
|
CGI
2445
DELISTED
Celadon Group Inc
CGI
| $1.27M | ﹤0.01% |
+144,832
| New | +$1.17M |
2016 Q3
0 quarters
|
|
|
GAU
2446
Galiano Gold
GAU
$573M
| $1.26M | ﹤0.01% |
301,400
-182,300
| -38% | -$769K |
2014 Q1
10 quarters
|
|
|
KS
2447
DELISTED
KapStone Paper and Pack Corp.
KS
| $1.26M | ﹤0.01% |
+66,800
| New | +$1.07M |
2016 Q3
0 quarters
|
|
2448
Kewaunee Scientific
KEQU
$97.8M
| $1.26M | ﹤0.01% |
53,000
+17,700
| +50% | +$391K |
2013 Q4
11 quarters
|
|
2449
Miller Industries
MLR
$596M
| $1.26M | ﹤0.01% |
55,200
-500
| -0.9% | -$10.8K |
2015 Q3
4 quarters
|
|
|
ACBI
2450
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $1.26M | ﹤0.01% |
83,900
+46,000
| +121% | +$693K |
2016 Q2
1 quarter
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.